Prepubertal Children With Growth Failure Associated With Primary Insulin-Like Growth Factor-1 (IGF-1) Deficiency
Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
This study is intended to determine whether twice daily weight based dosing with recombinant
human insulin-like growth factor (rhIGF-1) will safely and effectively increase the growth of
prepubertal children with short stature associated with low IGF-1 levels but who produce
sufficient growth hormone (GH). Subjects will be randomized to either an observation arm or
to active treatment.